Suchen
LivaNova PLC
LIVNZur Watchlist hinzufügen
80.140USD
-0.910-1.12%
Handelsschluss 07-31 16:00（ET）Kurse um 15 Minuten verzögert
4.40BMarktkapitalisierung
40.53KGV TTM
mehr Informationen über LivaNova PLC Unternehmen
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
LivaNova PLC Informationen
BörsenkürzelLIVN
Name des UnternehmensLivaNova PLC
IPO-datumOct 19, 2015
CEOMakatsaria (Vladimir A)
Anzahl der mitarbeiter2900
WertpapierartOrdinary Share
GeschäftsjahresendeOct 19
Addresse20 Eastbourne Terrace
StadtLONDON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited Kingdom
PostleitzahlW2 6LG
Telefon442033250662
Websitehttps://www.livanova.com/
BörsenkürzelLIVN
IPO-datumOct 19, 2015
CEOMakatsaria (Vladimir A)
Führungskräfte von LivaNova PLC
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
37.57K
+13.31%
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
12.62K
+28.18%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Ms. Brooke Story
Ms. Brooke Story
Independent Director
Independent Director
9.79K
+36.33%
Mr. Francesco Bianchi
Mr. Francesco Bianchi
Independent Director
Independent Director
9.58K
+24.58%
Mr. Michael Damon Hutchinson
Mr. Michael Damon Hutchinson
Senior Vice President, Chief Legal Officer, Company Secretary
Senior Vice President, Chief Legal Officer, Company Secretary
6.80K
--
Ahmet Tezel
Ahmet Tezel
Senior Vice President, Chief Innovation Officer
Senior Vice President, Chief Innovation Officer
6.09K
+31.74%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Alex Shvartsburg
Mr. Alex Shvartsburg
Chief Financial Officer
Chief Financial Officer
44.65K
--
Mr. William A. Kozy
Mr. William A. Kozy
Independent Chairman of the Board
Independent Chairman of the Board
37.57K
+13.31%
Ms. Stephanie Bolton
Ms. Stephanie Bolton
President, Global Epilepsy
President, Global Epilepsy
22.19K
+42.53%
Mr. Todd C. Schermerhorn
Mr. Todd C. Schermerhorn
Independent Director
Independent Director
12.62K
+28.18%
Dr. Sharon O'Kane, Ph.D.
Dr. Sharon O'Kane, Ph.D.
Independent Director
Independent Director
11.30K
--
Franco Poletti ,
Franco Poletti ,
President, Cardiopulmonary Business Unit
President, Cardiopulmonary Business Unit
10.97K
+17.36%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von LivaNova PLC?
Die fünf größten Anteilseigner von LivaNova PLC sind: Mr. Alex Shvartsburg
Wie viele Institutionen halten Anteile an LivaNova PLC (LIVN)?
Mit Stand vom 2026Q1 halten 609 Institutionen Anteile an LivaNova PLC, mit einem Gesamtmarktwert von etwa 60.49M, was 110.12% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -11258417.00 gestiegen.